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Summary
STUDY/PRINCIPLES: Arrythmogenic right ventricular
cardiomyopathy/dysplasia (ARVC/D) is an autosomal-
dominantly inherited disease caused by mutations in genes
encoding desmosomal proteins and is characterised by
fibrofatty replacement occurring predominantly in the right
ventricle and can result in sudden cardiac death. Naxos and
Carvajal syndrome, autosomal recessive forms of ARVC/
D, are characterised by involvement of the right and/or left
ventricle in association with palmoplantar keratoderma and
woolly hair. The aim of the present study has been to screen
for mutations in the desmosomal protein genes of two un-
related patients with Naxos-Carvajal syndrome.
METHODS AND RESULTS: Desmosomal protein genes
were screened for mutations by polymerase chain reaction
as well as direct sequencing approach. In each patient we
Abbreviations
ARVC/D Arrhythmogenic right ventricular cardiomyopathy/
dysplasia
DCM Dilated cardiomyopathy
DSC Desmocollin-2 gene
DSG2 Desmoglein-2 gene
DSP Desmoplakin gene
ICD Implantable cardioverter defibrillator
JUP Plakoglobin gene
LV Left ventricular/ventricle
LVEF Left ventricular ejection fraction
MRI Magnetic resonance tomography
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PKP2 Plakophilin-2 gene
RV Right ventricular/ventricle
RYR2 Cardiac ryanodine receptor 2
SCD Sudden cardiac death
TGFB3 Transforming growth factor-beta 3
TMEM43 Transmembrane protein 43
TTE Transthoracic echocardiography
identified a single heterozygous de novo mutation in the
desmoplakin gene DSP, p.Leu583Pro and p.Thr564Ile,
leading to severe combined cardiac/dermatological and
cardiac/dermatological/dental phenotypes. The DSP mis-
sense mutations are localised in the N terminal domain of
desmoplakin.
CONCLUSION: The identified variations in DSP involve
highly conserved residues. Moreover, the variations are de
novo mutations and they are localised in critical protein
domains that appear to be mutation hot spots. We assume
that these heterozygous variations are causal for the mixed
Naxos-Carvajal syndrome phenotype in the screened pa-
tients.
Key words: arrhythmogenic right ventricular
cardiomyopathy/dysplasia; Naxos-Carvajal syndrome;
autosomal-recessive; desmoplakin gene; de novo
mutations; mutation hot spots
Introduction
Arrhythmogenic Right Ventricular Cardiomyopathy/Dys-
plasia (ARVC/D) is an autosomal-dominantly inherited
disease characterised by fibrofatty replacement predomin-
antly of the right ventricle (RV) and can clinically lead to
heart failure, arrhythmias and sudden cardiac death (SCD)
[1]. Recently new diagnostic criteria for ARVC/D have
been proposed in order to improve diagnosis [2].
In 30–50% of cases ARVC/D is a familial disease with
incomplete penetrance. Most genes involved in ARVC/D
encode desmosomal proteins, in addition mutations in the
genes encoding the transforming growth factor-beta 3
(TGFB3), transmembrane protein 43 (TMEM43) and car-
diac ryanodine receptor 2 (RYR2) have been identified re-
cently. RYR2 mutations are still discussed controversially
[3]. When genes encoding proteins are systematically
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screened in ARVC/D patients, most mutations are found
in the gene plakophilin-2 (PKP2) (31%), followed by the
desmoglein-2 (DSG2) (10%), desmoplakin (DSP) (4.5%)
and desmocollin-2 (DSC2) (1.5%) genes [4]. In this recent
French study [4] it has been shown that mutations in the
DSG2 gene were more frequently responsible for cardiac
phenotypes with left ventricular (LV) involvement. In line
with the recent French data [4], PKP2 mutations were most
frequently identified to be causal for ARVC/D in a study of
the Dutch population [5].
Autosomal-recessive forms of ARVC/D often manifest as
Naxos and Carvajal syndrome. In Naxos disease caused
by homozygous plakoglobin (JUP) mutations, ARVC/D in-
volving predominantly the RV is associated with palmo-
plantar keratoderma and woolly hair, whereas in Carvajal
disease caused by homozygous DSP mutations, patients de-
velop LV involvement combined with palmoplantar kerat-
oderma and woolly hair.
Evidence for wide genetic heterogeneity of ARVC/D and
Naxos and Carvajal syndrome was recently summarised in
review papers [6, 7] including mutations with pathogenic
potential in proteins which are located at or in the com-
posite junction of the intercalated disk in connecting mam-
malian cardiomyocytes. Besides desmosomal proteins, an
increasing number of non-desmosomal proteins seem to be
involved in the disease development, e.g. lamin A/C, striat-
in, titin and desmin [6, 7].
In this study we report on two unrelated patients with
Naxos-Carvajal disease caused by heterozygous de novo
mutations in the DSP gene. Both patients had severe cardi-
ac phenotypes mainly involving the RV or the LV, resulting
in implantation of a cardioverter defibrillator (ICD). The
mutations were not identified in the maternal and paternal
chromosomes, thus both mutations are considered to be de
novo mutations.
Methods and results
Clinical evaluation case 1
The index patient was diagnosed with a bicuspid aortic
valve and mild aortic stenosis due to a 2/6 systolic heart
murmur at the age of two months. At the age of two years,
the patient developed striate palmoplantar keratoderma and
progressive erythemato-squamous plaques localised on el-
bows and knees and woolly hair (fig. 1A–E). The eyebrows
and eyelashes were scarce and all nails showed some dys-
trophies. Dental abnormalities were absent. At the age of
seven years, transthoracic echocardiography (TTE) re-
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Figure 1
Dermatological phenotype,and genetic screening of case 1.
A All nails show dystrophic nail plates.
B Striate keratoderma of the palms.
C Plantar keratoderma.
D Erythemato-squamous skin lesions on the knee.
E Curly woolly hair.
F Electropherograms of the desmoplakin mutation and of the wild type: a heterozygous variant in DSP, c.1748 T>C, was identified, resulting in
the missense mutation p.Leu583Pro at a heterozygous state.
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vealed mild LV-involvement with wall motion abnormality
of the posterior wall. Three years later the LV was slightly
dilated with mild to moderate decreased systolic function
and diastolic dysfunction. Holter-ECG revealed no
ventricular or atrial arrhythmias. Rapid disease progression
was seen in the follow-up TTE with severe dilated cardi-
omyopathy (DCM) of both ventricles, severely reduced LV
systolic function (LVEF 19%) and moderate aortic stenos-
is (peak gradient 42 mm Hg, underestimated by markedly
reduced LVEF). Cardiac magnetic resonance tomography
(MRI) confirmed the TTE findings; late-enhancement se-
quences revealed inhomogeneous areas of probable fibrosis
in the LV but no late enhancement of the RV. Balloon valv-
uloplasty was performed and an ICD was implanted. Last
follow up performed at the age of 13 years showed DCM
with mild aortic stenosis (peak gradient 21 mm Hg, un-
derestimated by markedly reduced LVEF) and a severely
reduced LVEF of 21%. Interrogation of the ICD was un-
eventful until the age of 14½ years, when ventricular fib-
rillation occurring during exercise was terminated by ad-
equate ICD shock.
Family history was completely normal. Both parents
(Caucasians) and one brother had no cardiac, dental or der-
matological diseases. History for SCD was negative.
Clinical evaluation case 2
The index patient is a female born from Caucasian non con-
sanguineous parents at term with normal birth and weight.
Her first tooth appeared at 11 months of age and, both cog-
nition and growth were normal during the following years
of life.
At the age of thirteen, the clinical examination was consist-
ent with curly and woolly blond hair with high frontal hair-
line. Although shape and dental enamel of teeth were nor-
mal, she had dental agenesis with missing teeth numbers
14, 15, 17, 25, 27, 35, 37, 45 and 47. Furthermore she ex-
hibited slight plantar keratosis, toe intertrigo and minimal
palmar keratosis. Nail examination revealed bilateral leu-
conychia of third and fourth toe whereas finger nails were
normal. While she had no cardiac symptoms, her resting
electrocardiogram showed regular sinus rhythm, left hemi
bundle-branch block and an epsilon wave. Her Holter ECG
recordings showed frequent ventricular premature beats.
Echocardiographic findings were consistent with severe
RV dilatation and slight LV enlargement from the apical-4
chamber view (fig. 2A, B). At 22 years, an ICD was im-
planted following three episodes of syncope.
Genetic screening and identification of two novel
heterozygous DSP mutations
The study complies with the Declaration of Helsinki. After
obtaining the written informed consent of each patient and
family member, DNA extraction was performed from peri-
pheral leucocytes using a classical phenol chloroform pro-
tocol. All coding exons of the genes PKP2, DSG2, DSC2,
DSP and JUP were amplified by polymerase chain reaction
(PCR) and directly sequenced in both strands. Analysis of
the entire coding sequence was performed by direct se-
quencing with the use of the Big Dye dideoxy-terminator
chemistry (Perkin Elmer) on ABI 3830 DNA sequencer
(PE Applied Biosystems) [4].
In case 1 a heterozygous variant in DSP, c.1748 T>C
(NM004415.2) was identified, resulting in a miss-sense
mutation p.Leu583Pro at a heterozygous state (fig. 1F).
In case 2, a heterozygous variant in DSP, c.1691 C>T
(NM004415.2) was identified, resulting in a miss-sense
mutation p.Thr564Ile at a heterozygous state (fig. 2C).
Both mutations were absent in 600 control chromosomes
from a Caucasian population and were not reported in the
exome variant server as well as the 1000 genome server
A B
C C
Figure 2
Transthoracic echocardiography, and genetic screening of case 2.
A Parasternal short axis view. Right atrium and right ventricular infundibulum are indicated. The right ventricular infundibulum diameter is
measured at the level of the aortic valve.
RA = right atrium; RV = right ventricular infundibulum.
B Apical four chamber view. Right ventricular trabeculations are visible at the free wall level.
RV = right ventricle; Trab = trabeculations; LV = left ventricle.
C Electrophoregrams of the desmoplakin mutation and of wild type: a heterozygous variant in DSP, c.1691 C>T, was identified, resulting in the
missense mutation p.Thr564Ile at a heterozygous state.
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databases. No additional mutation was found in the other
four genes encoding desmosomal proteins.
The two mutations are located in the highly conserved do-
main. The effect of mutated residues was predicted as dam-
aging by two among the three appropriate softwares (Poly-
phen, SIFT, Align AGVGD) used in our laboratory. Thus,
we considered these miss-sense mutations as causal for the
phenotypes. Mutation screening of the first degree relatives
was secondarily performed but did not identify the fam-
ily mutation in either of the parents of both patients, or
in the sister of case 2. A paternity test was carried out in
each of the families using the AmpF/STR SGM Plus® Pcr
Amplification Kit (Applied Biosystems) that includes the
study of ten different short tandem repeats, confirming that
the alleged father was the biological one in each case. We
therefore conclude that the probands both carried a de novo
mutation in DSP.
Discussion
In this study we identified a single de novo heterozygous
DSP mutation in each of the patients leading to combined
cardiac/dermatological and cardiac/dermatological/dental
phenotypes predominantly involving the LV or the RV. The
phenotypes mostly resemble Naxos-Carvajal syndrome,
which belong to the large spectrum of ectodermal dysplasi-
as [8].
The phenotype of patient 1 was characterised by bi-
ventricular predominant LV involvement with palmo-
plantar keratoderma and woolly hair. In patient 2 the phen-
otype was predominant RV involvement with mainly RV
dilation, associated with palmoplantar keratoderma and
dental involvement.
Today numerous allelic variants of DSP mutations are
known. Striate keratosis palmoplantares [9] and skin
fragility-woolly hair syndrome [10] are phenotypes affect-
ing the skin and are mostly caused by compound hetero-
zygous DSP mutations.
In contrast, the genetic basis of acantholytic lethal epiderm-
iolysis bullosa is compound heterozygous or homozygous
DSP mutations [11, 12].
Heterozygous DSP mutations can either lead to a pure car-
diac or a pure dermatological phenotype: ARVC/D type 8
is caused by heterozygous DSP mutations [13]. Only a few
heterozygous DSP mutations have been identified leading
Figure 3
Structural organisation of desmoplakin and the desmoplakin gene
(DSP). Desmoplakin, a big molecule (2871 AA) composed of three
domains, is a critical protein of the desmosomal junction that serves
to anchor the cytoskeleton to the plasma membrane. Desmoplakin
exists in two isoforms: the longer desmoplakin I and the shorter
desmoplakin II which is not expressed in the heart.
to pure dermatological phenotypes. In a family with a stri-
ate subtype of palmoplantar keratoderma a nonsense DSP
mutation in the amino terminal domain of desmoplakin was
identified [9].
The composed cardiac/dermatological phenotype caused
by homozygous DSP mutations is known as Carvajal dis-
ease, characterised by epidermolytic palmoplantar kerato-
derma with woolly hair and dilated cardiomyopathy [14].
The cardiac phenotype of the patients in this study [14] was
exclusively DCM.
The first recessive mutation, a deletion in DSP, was associ-
ated with a phenotype consistent for generalised striate ker-
atoderma, woolly hair and DCM of the LV [15]. In a study
of Alcalai et al. [16], a homozygous DSP miss-sense muta-
tion was identified in a large family with a high rate of con-
sanguinity. The clinical phenotype caused by DSP homozy-
gosity was characterised by foliaceous pemphigous, woolly
hair and ARVC/D without LV involvement [15]. The het-
erozygous mutation carriers did not reveal any cardiac or
dermatological abnormalities [15].
In our study both patients showed mixed cardiac/derma-
tological or cardiac/dermatological/dental phenotypes and
each carried a single heterozygous mutation in DSP. Com-
pound heterozygosity was at least excluded for the PKP2,
DSG2, DSC2 and JUP genes.
It is still under investigation why heterozygous DSP muta-
tion can lead to wide phenotype heterogeneity. Genotype
heterogeneity with unknown variants in the major genes or
polymorphisms and unknown factors might be modulating
factors. Evidence for genetic heterogeneity specifically in
Carjaval syndrome with dental involvement was discussed
in a paper of Nehme recently [17]. In this paper [17] DSP
mutations were excluded in a patient with Carjaval syn-
drome. Due to the wide genotype and phenotype hetero-
geneity in ARVC/D and Naxos and Carvajal syndrome it
can be speculated that the complex phenotypes in our pa-
tients might be a “common” desmoplakin mutation condi-
tion. Such conditions could be based on an autosomal re-
cessive or autosomal dominantly inheritance background.
Desmosomal structure and desmoplakin
The desmosomal plaque consists of two distinct electron
dense regions: one close to the membrane of the low dens-
ity region and one to the high density region further from
the membrane, separated by a clear region [18]. The des-
mosomal proteins involved in desmosomal structure in-
clude plakoglobin, plakophilins, desmocollins, des-
mogleins and the plakins with desmoplakin. Desmoplakin
is a critical protein of the desmosomal junction that serves
to anchor the cytoskeleton to the plasma membrane. Histor-
ically the desmoplakin localisation was first demonstrated
in 1981 (for review, see [19]). Desmoplakin exists in two
isoforms: the longer desmoplakin I and the shorter desmo-
plakin II which is not expressed in the heart. Desmoplakin
is a big molecule (2871 AA) composed of three domains
(fig. 3). The desmoplakin N-terminal of 1056 AA contains
a plakin domain (580AA) that is thought to be responsible
for targeting desmoplakin to junction by mediating interac-
tions with plakophilin and plakoglobin [20].
The C-terminal domain (1946-2871 AA) is predicted to
interact with intermediate filaments. The structure of the
Original article Swiss Med Wkly. 2012;142:w13670
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C-terminal domains features three plakin repeat domains
called A, B, and C. The core of the molecule (1057-1945
AA) is composed of a helical domain. Two molecules of
desmoplakin are predicted to form dimers based on a coiled
formation between their two central cores [21, 22].
Consequences of the missense
mutation on structure
It is likely that various mechanisms are involved in ex-
plaining the different phenotypes, depending on the type of
mutation and on their positions.
The c7901Del homozygous mutation located in c-terminal
domain of DSP causes a premature stop and results in a
truncated protein. The loss of the desmoplakin tail impairs
interaction with intermediate filaments in the heart, the skin
and the hair resulting in a combination of woolly hair,
palmoplantar keratoderma and LV DCM [14]. C-termin-
al compound mutations (nonsense and miss-sense muta-
tions) have been reported by Mahoney et al. [23]. The non-
sense mutation is thought to lead to a truncated protein,
and the associated missense mutation (c.7964 C>A,
p.Ala2655Asn) is thought to alter intermolecular interac-
tions with intermediate filaments. The resulting phenotype
includes cutaneous blisters, epidermolytic palmoplantar
keratoderma, nail dystrophy, enamel dysplasia, woolly hair
and cardiomyopathy [23]. Compound heterozygosity with
amino terminal missense mutations (p.Arg2366Cys) and
carboxy terminal nonsense mutations (p.Gln664X) are in-
volved in severe keratoderma of hands and feet and woolly
hair without cardiomyopathy [10].
For the heterozygous nonsense mutation, pGln331X, hap-
loinsufficiency was the proposed physiopathological mech-
anism [9]. The relevance of haploinsufficiency for des-
moplakin causing inherited dermatological phenotypes was
further proposed by Whittock et al. [24].
Almost 50 mutations have been described in the first 15 ex-
ons coding N terminal domain. Among these mutations, 10
to 15 are variants of unknown significance. Four of these
mutations are in the region of interest of the protein (table
1). The missense mutation p.Ala566Thr reported by Basso
et al [25] was associated with a second missense mutation
in DSP, p.Lys470Glu. All the patients in this study [25]
were diagnosed with ARVD.
Recently, a heterozygous mutation has been described by
Chalabreysse et al. [26] in a family with oligodontia asso-
ciated with Carvajal/Naxos disease. The missense mutation
p.Ser597Leu [26] is in the same region of the desmoplakin
protein as the present mutations and the patients’ pheno-
types resemble each other except for the presence of hypo-
/oligodontia. This observation suggests a key role for the
desmoplakin region (564-597), which may be involved in
the interactions with plakophilin or plakoglobin. Addition-
al studies are needed in order to explain the role of this key
region.
Besides the direct effects of the desmoplakin mutations on
the myocardial composite, indirect mechanisms may play a
key role in early phenotype development [27, 28].
In a murine model, conditional genetic deletion of one des-
moplakin allele caused connexin mislocation which pre-
cedes any overt histological abnormalities in ARVD/C
[27]. The importance of the connexin-desmosomal protein
interdependence resulting in ventricular conduction abnor-
malities preceding the histopathological ARVC/D phen-
otype has also been shown in an in vitro study of an
ARVC/D patient’s myocardial tissue [28].
In the present study, two single heterozygous DSP mis-
sense mutations in two unrelated patients were found in
the N terminal domain of the desmoplakin protein. These
variants involve high conserved residues. Moreover, these
mutations are de novo and localised in critical protein do-
mains that appear to be mutation hot spots in residues 250
to 604 [29]. We assume that these variants are the causal
mutations because of their absence in 300 controls.
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Figure 1
Dermatological phenotype, and genetic screening of case 1.
A All nails show dystrophic nail plates.
B Striate keratoderma of the palms.
C Plantar keratoderma.
D Erythemato-squamous skin lesions on the knee.
E Curly woolly hair.
F Electropherograms of the desmoplakin mutation and of the wild type: a heterozygous variant in DSP, c.1748 T>C, was identified, resulting in
the missense mutation p.Leu583Pro at a heterozygous state.
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Figure 2
Transthoracic echocardiography, and genetic screening of case 2.
A Parasternal short axis view. Right atrium and right ventricular infundibulum are indicated. The right ventricular infundibulum diameter is
measured at the level of the aortic valve.
RA = right atrium; RV = right ventricular infundibulum.
B Apical four chamber view. Right ventricular trabeculations are visible at the free wall level.
RV = right ventricle; Trab = trabeculations; LV = left ventricle.
C Electrophoregrams of the desmoplakin mutation and of wild type: a heterozygous variant in DSP, c.1691 C>T, was identified, resulting in the
missense mutation p.Thr564Ile at a heterozygous state.
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Figure 3
Structural organisation of desmoplakin and the desmoplakin gene (DSP). Desmoplakin, a big molecule (2871 AA) composed of three domains,
is a critical protein of the desmosomal junction that serves to anchor the cytoskeleton to the plasma membrane. Desmoplakin exists in two
isoforms: the longer desmoplakin I and the shorter desmoplakin II which is not expressed in the heart.
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